Search
Search Results
- Publication:
- Washington, D.C. : AARP, [2009]
- Subject(s):
- Cost Sharing
Deductibles and Coinsurance
Drug Costs
Formularies as Topic
Aged
Insurance, Pharmaceutical Services -- economics
Medicare Part D -- economics
Prescription Drugs -- economics
Humans
United States
- Author(s):
- Purvis, Leigh, author
- Publication:
- Washington, DC : AARP Public Policy Institute, March 2017
- Subject(s):
- Drug Costs
Insurance Coverage
Medicare Part D -- economics
Cost Savings
Deductibles and Coinsurance
Financing, Personal
Medicare -- legislation & jurisprudence
Humans
United States
United States.
- Author(s):
- Carter, Elizabeth A., author
Purvis, Leigh, author
- Publication:
- Washington, DC : AARP Public Policy Institute, August 2018
- Subject(s):
- Dementia -- drug therapy
Dementia -- economics
Drug Costs
Inappropriate Prescribing -- economics
Aged
Cholinesterase Inhibitors -- economics
Cholinesterase Inhibitors -- therapeutic use
Cost Savings
Drug Therapy, Combination
Memantine -- economics
Memantine -- therapeutic use
Humans
United States
- Author(s):
- Johnson, Bill, author
Rodriguez, Sally, author
- Publication:
- Washington, DC : Health Care Cost Institute, February 2018
- Subject(s):
- Financing, Personal
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Drug Costs
Forecasting
Insurance, Health -- economics
Insurance, Pharmaceutical Services -- economics
Private Sector
Humans
United States
- Author(s):
- Johnson, Bill, author
- Publication:
- Washington, DC : Health Care Cost Institute, April 2018
- Subject(s):
- Drug Costs
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Multiple Sclerosis -- economics
Multiple Sclerosis -- drug therapy
Dihydroorotate Oxidase -- antagonists & inhibitors
Dimethyl Fumarate -- economics
Fingolimod Hydrochloride -- economics
Forecasting
Glatiramer Acetate -- economics
Interferon beta-1a -- economics
Interferon beta-1b -- economics
Humans
United States
- Publication:
- Washington, DC : United States Government Accountability Office, November 2017
- Subject(s):
- Drug Costs
Drug Industry -- economics
Economics, Pharmaceutical -- trends
Pharmaceutical Research -- economics
Pharmaceutical Research -- trends
Antitrust Laws
Biological Products -- economics
Drug Approval -- economics
Drug Development -- economics
Drug Development -- trends
Economic Competition
Forecasting
Orphan Drug Production -- economics
Taxes
Humans
United States
National Institutes of Health (U.S.)
- Publication:
- Washington, DC : United States Government Accountability Office, December 2017
- Subject(s):
- Drug Costs
Health Care Sector
Health Expenditures
Medicare Part B -- economics
Insurance, Health, Reimbursement
Medicare Part B -- statistics & numerical data
Humans
United States
- Publication:
- Washington, D.C. : AARP Knowledge Management, c2005
- Subject(s):
- Data Collection
Drug Costs
Drug Prescriptions -- economics
Pharmaceutical Preparations -- economics
Adult
Aged
Insurance, Pharmaceutical Services -- economics
Medical Assistance -- economics
Medicare -- economics
Middle Aged
State Government
Female
Humans
Male
Nebraska
United States
- Publication:
- Washington, D.C. : AARP Knowledge Management, c2007
- Subject(s):
- Drug Costs
Drug Prescriptions -- economics
Health Services Accessibility
Medicare Part D
Patient Satisfaction
Aged
Data Collection
Drugs, Generic
Health Status
Insurance Coverage
Insurance, Pharmaceutical Services
Middle Aged
Humans
United States
- Publication:
- Washington, D.C. : AARP Public Policy Institute, c2008
- Subject(s):
- Delivery of Health Care -- statistics & numerical data
Drug Costs
Drug Prescriptions -- economics
Health Care Costs
Health Expenditures
Insurance, Pharmaceutical Services
Costs and Cost Analysis
Humans
United States
